203
Views
0
CrossRef citations to date
0
Altmetric
Articles

Heavy prescription over time leading to opioid dependence

, , , , &
Pages 579-583 | Received 08 Sep 2017, Accepted 26 Mar 2018, Published online: 13 Apr 2018

References

  • Berland, D., & Rodgers, P. (2012). Rational use of opioids for management of chronic nonterminal pain. American Family Physician, 86(3), 252–258.
  • Boscarino, J., Hoffman, S., & Han, J. (2015). Opioid-use disorder among patients on long-term opioid therapy: Impact of final DSM-5 diagnostic criteria on prevalence and correlates. Substance Abuse and Rehabilitation, 6, 83. doi:10.2147/SAR.S85667
  • Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006). Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain, 10(4), 287–333. doi:10.1016/j.ejpain.2005.06.009
  • Breivik, H., Eisenberg, E., & O’Brien, T. (2013). The individual and societal burden of chronic pain in Europe: The case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health, 13(1), 1229. doi:10.1186/1471-2458-13-1229
  • Chou, R. (2009). 2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: What are the key messages for clinical practice? Polskie Archiwum Medycyny Wewnętrznej, 119(7–8), 469–477.
  • Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., … Miaskowski, C. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain: Official Journal of the American Pain Society, 10(2), 113–130. doi:10.1016/j.jpain.2008.10.008
  • Dowel, D., Haegerich, T., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain — United States, 2016. Recommendations and Reports, 65(1), 1–49. doi:10.15585/mmwr.rr6501e1
  • Edlund, M. J., Martin, B. C., Devries, A., Fan, M.-Y., Braden, J. B., & Sullivan, M. D. (2010). Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: The TROUP study. The Clinical Journal of Pain, 26(1), 1–8. doi:10.1097/AJP.0b013e3181b99f35
  • Edlund, M. J., Sullivan, M., Steffick, D., Harris, K. M., & Wells, K. B. (2007). Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Medicine, 8(8), 647–656. doi:10.1111/j.1526-4637.2006.00200.x
  • Fishbain, D. A., Cole, B., Lewis, J., Rosomoff, H. L., & Rosomoff, R. S. (2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Medicine, 9(4), 444–459. doi:10.1111/j.1526-4637.2007.00370.x
  • Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014). Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addictive Behaviors, 39(3), 520–531. doi:10.1016/j.addbeh.2013.11.022
  • Gourlay, D. L., Heit, H. A., & Almahrezi, A. (2005). Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Medicine, 6(2), 107–112. doi:10.1111/j.1526-4637.2005.05031.x
  • Grattan, A., Sullivan, M. D., Saunders, K. W., Campbell, C. I., & Von Korff, M. R. (2012). Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Annals of Family Medicine, 10(4), 304–311. doi:10.1370/afm.1371
  • Hassett, A. L., Aquino, J. K., & Ilgen, M. A. (2014). The risk of suicide mortality in chronic pain patients. Current Pain and Headache Reports, 18(8), 436. doi:10.1007/s11916-014-0436-1
  • Jamison, R. N., Edwards, R. R., Liu, X., Ross, E. L., Michna, E., Warnick, M., & Wasan, A. D. (2013). Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients. Pain Practice : the Official Journal of World Institute of Pain, 13(3), 173–181. doi:10.1111/j.1533-2500.2012.00575.x
  • Jamison, R. N., Ross, E. L., Michna, E., Chen, L. Q., Holcomb, C., & Wasan, A. D. (2010). Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A randomized trial. PAIN, 150(3), 390–400. doi:10.1016/j.pain.2010.02.033
  • Jan, S. A. (2010). Introduction: Landscape of opioid dependence. Journal of Managed Care Pharmacy, 16(1Suppl B), 4–8. doi:10.18553/jmcp.2010.16.S1-B.4
  • Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 125(1–2), 8–18. doi:10.1016/j.drugalcdep.2012.07.004
  • Kaye, A. D., Jones, M. R., Kaye, A. M., Ripoll, J. G., Galan, V., Beakley, B. D., … Manchikanti, L. (2017a). Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1. Pain Physician, 20, 93–109.
  • Kaye, A. D., Jones, M. R., Kaye, A. M., Ripoll, J. G., Galan, V., Beakley, B. D., … Manchikanti, L. (2017b). Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2). Pain Physician, 20, 111–133.
  • Manchikanti, L., Giordano, J., Boswell, M. V., Fellows, B., Manchukonda, R., & Pampati, V. (2007). Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. Journal of Opioid Management, 3(2), 89–100. doi:10.5055/jom.2007.0045
  • Morley, K. I., Ferris, J., Winstock, A. R., & Lynskey, M. T. (2017). Polysubstance use and misuse or abuse of prescription opioid analgesics. Pain, 1. doi:10.1097/j.pain.0000000000000892
  • Park, T. W., Saitz, R., Nelson, K. P., Xuan, Z., Liebschutz, J. M., & Lasser, K. E. (2016). The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain. Substance Abuse, 37(4), 516–520. doi:10.1080/08897077.2016.1179242
  • Rehm, J., Marmet, S., Anderson, P., Gual, A., Kraus, L., Nutt, D. J., … Gmel, G. (2013). Defining substance use disorders: Do we really need more than heavy use? Alcohol and Alcoholism, 48(6), 633–640. doi:10.1093/alcalc/agt127
  • Scherrer, J. F., Salas, J., Lustman, P. J., Burge, S., Schneider, F. D., & Residency Research Network of Texas (Rrnet) Investigators. (2015). Change in opioid dose and change in depression in a longitudinal primary care patient cohort. PAIN, 156(2), 348–355. doi:10.1097/01.j.pain.0000460316.58110.a0
  • Shei, A., Hirst, M., Kirson, N., Enloe, C., Birnbaum, H., & Dunlop, W. (2015). Estimating the health care burden of prescription opioid abuse in five European countries. Clinico Economics and Outcomes Research, 7, 477. doi:10.2147/CEOR.S85213
  • Sullivan, M. D., Edlund, M. J., Fan, M.-Y., DeVries, A., Braden, J. B., & Martin, B. C. (2010). Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. PAIN, 150(2), 332–339. doi:10.1016/j.pain.2010.05.020
  • The British Pain Society. (2012). Opioids for persistent pain: Summary of guidance on good practice from the British Pain Society. British Journal of Pain, 6(1), 9–10. doi:10.1177/2049463712436536
  • Toblin, R. L., Paulozzi, L. J., Logan, J. E., Hall, A. J., & Kaplan, J. A. (2010). Mental illness and psychotropic drug use among prescription drug overdose deaths: A medical examiner chart review. The Journal of Clinical Psychiatry, 71(4), 491–496. doi:10.4088/JCP.09m05567blu
  • Wasan, A. D., Michna, E., Edwards, R. R., Katz, J. N., Nedeljkovic, S. S., Dolman, A. J., … Jamison, R. N. (2015). Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain. Anesthesiology, 123(4), 861–872. doi:10.1097/ALN.0000000000000768
  • Yi, P., & Pryzbylkowski, P. (2015). Opioid induced hyperalgesia. Pain Medicine, 16(suppl 1), S32–S36. doi:10.1111/pme.12914

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.